ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
16.73
+0.02 (0.12%)
At close: Oct 9, 2026, 4:00 PM EDT
16.57
-0.16 (-0.96%)
After-hours: Oct 9, 2026, 7:46 PM EDT
ArriVent BioPharma Employees
ArriVent BioPharma had 77 employees as of December 31, 2025. The number of employees increased by 25 or 48.08% compared to the previous year. That makes ArriVent BioPharma the 32,889th largest employer in the world and 4,288th in the United States.
Employees
77
Change (1Y)
25
Growth (1Y)
48.08%
Revenue / Employee
n/a
Profits / Employee
-$2,132,597
Market Cap
824.92M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 77 | 25 | 48.08% |
| Dec 31, 2024 | 52 | 12 | 30.00% |
| Dec 31, 2023 | 40 | - | - |
| Sep 30, 2023 | 42 | - | - |
| Jun 30, 2023 | 40 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ardelyx | 489 |
| Ginkgo Bioworks Holdings | 485 |
| Geron | 258 |
| Monte Rosa Therapeutics | 173 |
| Sana Biotechnology | 142 |
| Helus Pharma | 100 |
| SpyGlass Pharma | 76 |
| Immix Biopharma | 21 |
AVBP News
- 2 days ago - ArriVent Biopharma price target lowered to $27 from $47 at H.C. Wainwright - TheFly
- 2 days ago - AVBP Investors with $100,000 in Losses Have Opportunity to Join ArriVent BioPharma, Inc. Fraud Investigation with SBS Law - Business Wire
- 2 days ago - AVBP SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving ArriVent BioPharma - PRNewsWire
- 3 days ago - ArriVent Biopharma price target lowered to $29 from $42 at BTIG - TheFly
- 3 days ago - ArriVent Biopharma price target lowered to $18 from $45 at Guggenheim - TheFly
- 3 days ago - ArriVent Biopharma price target lowered to $20 from $40 at Citi - TheFly
- 3 days ago - ArriVent Biopharma price target lowered to $22 from $47 at Clear Street - TheFly
- 3 days ago - ArriVent Biopharma price target lowered to $22 from $45 at Jones - TheFly